Viewing Study NCT04689204


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-01-02 @ 2:17 PM
Study NCT ID: NCT04689204
Status: COMPLETED
Last Update Posted: 2025-01-24
First Post: 2020-12-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies
Sponsor: He Huang
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: BHCT-CTA30X-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View